Home›Companies›Biotech & Pharma›LifeCyte

LifeCyte Innovations, Inc.

Develops therapies for people with age-related conditions involving chronic inflammation.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Aug 20, 2026·Suggest an edit

About LifeCyte

LifeCyte is a private company based in Greensboro, Georgia, incorporated in 2024 in Iowa. It has reported $1,000,000 raised in one offering on Form D since August 2026. Its chief executive is Kenneth Brown.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 12, 2026Aug 20, 2026$1,000,000of $5.0M target3$333KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on LifeCyte's Form D filed Aug 20, 2026.

KB
Kenneth Brown
CEO & Co-Founder, director
MM
Michael Moorhead
Executive officer and director

Sources

  1. SECLifeCyte Innovations, Inc. filing history